The Kaplan–Meier survival analysis and log-rank test revealed that colorectal cancer patients with low tumor HNF3β protein expression tended to have worse 5-year OS and PFS than patients with high tumor HNF3β protein expression (P < 0.001, both; Table 2). This evidence concerns the gene FOXA2 and colorectal cancer.